Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
DOW JONES
S&P 500
NASDAQ 100
TSX COMP
NIKKEI 225
»
More Indexes
Currency / Forex
EUR / USD
GBP / USD
USD / JPY
USD / CAD
AUD / USD
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Let’s all cycle!
Fintechs
Ageing Population
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Nasdaq
>
GlycoMimetics, Inc.
GLYC
GLYCOMIMETICS, INC.
(GLYC)
Add to my list
Report
Real-time Estimate Cboe BZX -
01/26 11:48:07 am
4.045
USD
-1.34%
01/07
GLYCOMIMETICS
: Drug Candidate For Acute Myeloid Leukemia Gets Chinese Regulator's Breakthrough Therapy Designation
MT
2020
GLYCOMIMETICS
: New Supportive Efficacy Data for GlycoMimetics' Rivipansel in Sickle Cell Acute Vaso-Occlusive Crisis Presented at 62nd ASH Annual Meeting and Exposition
BU
2020
Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates Buy Rating
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Sector news Bio Therapeutic Drugs
11:04a
REGENERON PHARMACEUTICALS
: Antibody Drug Temporarily Protects Against Covid-19,..
DJ
10:51a
DGAP-DD
: Evotec SE english
DJ
10:28a
GENMAB A/S
: SVB Leerink Adjusts Price Target on Genmab A/S to $38 From $34, Mai..
MT
09:10a
VERTEX PHARMACEUTICALS
: Gets FDA Priority Review of Expanded Trikafta Age Range
DJ
09:04a
Johnson & Johnson's Profit Is Boosted by Pharmaceuticals Business --Update
DJ
08:20a
Johnson & Johnson Profit Is Boosted by Pharmaceuticals Business
DJ
08:04a
REGENERON
: Interim Data Positive With REGEN-COV as Passive Vaccine to Prevent C..
DJ
02:46a
Germany backs EU export restrictions on vaccine after supply cuts
RE
02:41a
ASTRAZENECA
: COVID-19 vaccine supplies continue to be tight, UK minister says
RE
01/25
Saudi Arabia to get 3 mln AstraZeneca shots in about a week from India
RE
01/25
Canadian gaming CEO resigns after being accused of flouting COVID-19 rules
RE
01/25
MODERNA
: U.S. CDC says 41.4 mln doses of COVID-19 vaccines distributed, 22.7 ml..
RE
01/25
Scarce niche syringes complicate U.S. plan to squeeze more COVID shots from P..
RE
01/25
AstraZeneca denies report vaccine less effective in elderly
RE
01/25
Moderna Developing Vaccine Booster Shot Against Virus Strain First Identified..
DJ
01/25
REFILE-COVID SCIENCE-Moderna shot protects against new virus variants; higher..
RE
01/25
Merck Scraps Covid-19 Vaccine Candidates -- Update
DJ
01/25
Saudi Arabia to get AstraZeneca shots in about a week from India
RE
01/25
Moderna Developing Vaccine Booster Shot Against Virus Strain First Identified..
DJ
01/25
EXCLUSIVE
: Pfizer wants India to order COVID-19 vaccine before pursuing approva..
RE
01/25
ULTRAGENYX PHARMACEUTICAL
: Credit Suisse Adjusts RARE UltraGenyx Pharmaceutical..
MT
01/25
MODERNA
: says it believes vaccine will work against new variants
RE
01/25
Moderna says COVID-19 vaccine expected to be protective against new variants
RE
01/25
KODIAK SCIENCES
: BMO Downgrades Kodiak Sciences to Market Perform From Outperfo..
MT
01/25
ALNYLAM PHARMACEUTICALS
: BMO Capital Downgrades Alnylam Pharmaceuticals to Mark..
MT
01/25
U.S. goal to squeeze more COVID shots from Pfizer vials hampered by syringe p..
RE
01/25
REGENERON PHARMACEUTICALS
: BMO Capital Upgrades Regeneron Pharmaceuticals to Ou..
MT
01/25
Need to hire problem-solvers boosts recruiter SThree
RE
01/25
EU to require advance registration of COVID-19 vaccine exports
RE
01/25
Merck Scraps Covid-19 Vaccine Candidates
DJ
01/25
Merck ends COVID vaccine program, cites inferior immune responses
RE
01/25
Hong Kong formally approves Fosun Pharma-BioNTech vaccine
RE
01/25
Hong Kong formally approves Fosun-BioNTech vaccine
RE
01/25
STHREE
: Final Results -2-
DJ
01/25
What you need to know about the coronavirus right now
RE
01/25
What you need to know about the coronavirus right now
RE
01/24
TATA IN TALKS TO LAUNCH MODERNA COVI
: Et
RE
01/24
MODERNA
: U.S. CDC says 21.8 million doses of COVID-19 vaccines administered
RE
01/23
MODERNA
: U.S. CDC says 41.4 mln doses of COVID-19 vaccines distributed, 20.5 ml..
RE
01/23
UK vaccine roll-out speeds up but doctors want quicker second dose
RE
01/23
AstraZeneca's Covid-19 Vaccine Shortfall Threatens EU Plans to Boost Inoculat..
DJ
01/22
AstraZeneca Warns of Covid-19 Vaccine Shortfall in Europe -- Update
DJ
01/22
39.9 MLN DOSES OF COVID-19 VACCINES
: U.s. cdc
RE
01/22
AstraZeneca Warns of Covid-19 Vaccine Shortfall in Europe
DJ
01/22
MODERNA
: Severe allergic reactions to Moderna vaccine appear rare -CDC report
RE
01/22
AstraZeneca's initial EU delivery volumes of COVID-19 vaccine to fall short
RE
01/22
PFIZER
: BioNTech in Vaccine Advance Purchase Agreement With Covax
DJ
01/22
MODERNA
: BofA Securities Adjusts Moderna PT to $140 From $130, Maintains Neutra..
MT
01/22
PRESS RELEASE
: Pfizer and BioNTech Reach -2-
DJ
01/22
PRESS RELEASE
: Pfizer and BioNTech Reach Agreement with COVAX for Advance Purch..
DJ
1
2
3
4
5
6
7
8
9
10
Next
Upcoming event on GLYCOMIMETICS, INC.
03/03/21
Jahr 2020 Ergebnisveröffentlichung (geplant)
Company calendar
Upcoming sector events
01/27/21
LONZA GROUP LTD
: Jahr 2020 Ergebnisveröffentlichung
02/01/21
VERTEX PHARMACEUTICALS INCORPORATED
: Jahr 2020 Ergebnisveröffentlichung
02/02/21
BIO-TECHNE CORPORATION
: Erstes Halbjahr 2021 Ergebnisveröffentlichung
02/03/21
QIAGEN N.V.
: Jahr 2020 Ergebnisveröffentlichung (geplant)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs
Slave